MedCity News September 7, 2021
Unleashed from restrictive norms for recruiting and interacting with patients, researchers are finding ways to bring more people into trials by simply making enrollment and participation accessible beyond restraints like geography and availability during “business hours.”
In a post-Covid world, we’re seeing a decade’s worth of reshaping within clinical trials solidify in less than a year. While the life sciences industry was making a slow build toward decentralized clinical trials and broader inclusion, Covid-19 exposed gaps in reach and efficiency that can no longer be ignored. Moving forward, industry leaders are focused on modernizing and “opening up” the model for operating clinical trials in these three categories:
- Recruiting
- Participating
- Monitoring
For enterprises in the life sciences industry, the...